Page last updated: 2024-10-28

hydralazine and Hyperoxia

hydralazine has been researched along with Hyperoxia in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Hyperoxia: An abnormal increase in the amount of oxygen in the tissues and organs.

Research Excerpts

ExcerptRelevanceReference
"In contrast, N2 breathing to terminal anoxia and intravenous hydralazine produced a negligible increase in Hb, but large reductions in HbO and HbT."1.33The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS. ( Connelly, JP; Griffiths, JR; Howe, FA; Robinson, SP; Springett, R, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Howe, FA1
Connelly, JP1
Robinson, SP1
Springett, R1
Griffiths, JR1

Other Studies

1 other study available for hydralazine and Hyperoxia

ArticleYear
The effects of tumour blood flow and oxygenation modifiers on subcutaneous tumours as determined by NIRS.
    Advances in experimental medicine and biology, 2005, Volume: 566

    Topics: Animals; Carbon Dioxide; Female; Hemoglobins; Hydralazine; Hyperoxia; Hypoxia; Magnetic Resonance Im

2005